Premium
Structure, function and tissue forms of the C‐terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin
Author(s) -
Sasaki Takako,
Fukai Naomi,
Mann Karlheinz,
Göhring Walter,
Olsen Björn R.,
Timpl Rupert
Publication year - 1998
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1093/emboj/17.15.4249
Subject(s) - domain (mathematical analysis) , biology , mathematics , mathematical analysis
The C‐terminal domain NC1 of mouse collagen XVIII (38 kDa) and the shorter mouse and human endostatins (22 kDa) were prepared in recombinant form from transfected mammalian cells. The NC1 domain aggregated non‐covalently into a globular trimer which was partially cleaved by endogenous proteolysis into several monomers (25–32 kDa) related to endostatin. Endostatins were obtained in a highly soluble, monomeric form and showed a single N‐terminal sequence which, together with other data, indicated a compact folding. Endostatins and NC1 showed a comparable binding activity for the microfibrillar fibulin‐1 and fibulin‐2, and for heparin. Domain NC1, however, was a distinctly stronger ligand than endostatin for sulfatides and the basement membrane proteins laminin‐1 and perlecan. Immunological assays demonstrated endostatin epitopes on several tissue components (22–38 kDa) and in serum (120–300 ng/ml), the latter representing the smaller variants. The data indicated that the NC1 domain consists of an N‐terminal association region (∼50 residues), a central protease‐sensitive hinge region (∼70 residues) and a C‐terminal stable endostatin domain (∼180 residues). They also demonstrated that proteolytic release of endostatin can occur through several pathways, which may lead to a switch from a matrix‐associated to a more soluble endocrine form.